Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01APGE144JANE HENDERSON plan to sell securities of APOGEE THERAPEUTICS INC under Form 144MEDIUM
JANE HENDERSON filed Form 144 to notify SEC of plan to sell 2000 units of APOGEE THERAPEUTICS INC securities around 2026-05-01, with aggregate market value of $165,780.00. The total outstanding units is 55998605.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 ...
Mid CapBiotechnology
2026-05-01IMVT144ROBERT G SUSMAN plan to sell securities of IMMUNOVANT INC under Form 144MEDIUM
ROBERT G SUSMAN filed Form 144 to notify SEC of plan to sell 2502 units of IMMUNOVANT INC securities around 2026-05-01, with aggregate market value of $67,916.79. The total outstanding units is 203532180.0. The amount planned to be sold represents 0.00% of total outstanding units; ...
Mid CapBiotechnology
2026-05-01CTNM144DANIEL LORRAIN plan to sell securities of Contineum Therapeutics, Inc. under Form 144MEDIUM
DANIEL LORRAIN filed Form 144 to notify SEC of plan to sell 4170 units of Contineum Therapeutics, Inc. securities around 2026-05-01, with aggregate market value of $53,459.40. The total outstanding units is 32673536.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in pas...
Small CapBiotechnology